GHK-Cu: The Complete Guide to Copper Peptide for Hair
With over 80 published studies, GHK-Cu is the most evidence-backed peptide for hair restoration. This guide covers mechanism, protocol, sourcing, and what to realistically expect.
GHK-Cu (Glycine-L-Histidine-L-Lysine·copper) is a naturally occurring tripeptide found in human plasma, saliva, and urine. It was first isolated from human albumin in 1973 by Loren Pickart, who spent the next five decades studying its effects on tissue remodeling. For hair specifically, the body of evidence is deeper than for any other peptide.
What It Does in Hair Follicles
GHK-Cu operates on multiple levels simultaneously, which is why it consistently outperforms single-mechanism compounds.
Wnt/β-catenin activation: The Wnt pathway is the master regulator of hair follicle development and cycling. GHK-Cu activates this pathway in dermal papilla cells, extending the anagen (growth) phase and increasing follicle size.
Stem cell activation: Hair follicle stem cells in the bulge region require specific signals to exit quiescence. GHK-Cu provides these signals, recruiting more stem cells into active follicle production.
VEGF upregulation: Like BPC-157, GHK-Cu stimulates VEGF, improving local blood supply. The combination of the two is therefore synergistic rather than redundant.
Anti-inflammatory action: GHK-Cu suppresses TNF-α and IL-1β, the primary cytokines that drive the chronic scalp inflammation associated with AGA.
Increased follicle size: In a 6-month double-blind study, topical GHK-Cu increased hair density by 42% and follicle diameter by 27% compared to placebo.
Protocol
The two administration routes each have advantages:
Topical: Requires a carrier for scalp penetration (DMSO, liposomes, or microneedling-assisted delivery). Less precise but easier to perform daily. Use 5–10 mg dissolved in 1 ml DMSO:saline (50:50) applied to the scalp before sleep.
Subcutaneous injection: More precise. 2–5 mg dissolved in bacteriostatic water injected subcutaneously at the hairline and vertex using a 29–31g insulin syringe. Daily or every other day.
For most users, we recommend starting with topical application with microneedling (0.5–1.0mm dermaroller) once weekly, combined with daily injection if comfortable with injection protocols.
Duration: 12 weeks minimum. Noticeable results typically begin at 8–10 weeks. Full results at 6–12 months of consistent use.
Realistic Expectations
GHK-Cu will not regrow hair in areas of complete follicle loss (scar tissue, extremely long-standing AGA). It works by rescuing compromised follicles and extending the productivity of active ones.
For Norwood 1–4 pattern hair loss with follicle miniaturization as the primary pathology, results are consistently strong in the research. For Norwood 5–7, it remains useful as part of the Foundation Routine but expectations should be adjusted.
Sourcing
GHK-Cu is available from multiple research peptide suppliers. Look for: - ≥98% purity by HPLC - Certificate of Analysis from third-party lab - Lyophilized powder (not pre-mixed solutions) - US-based manufacturer with verifiable testing